Teva Pharmaceutical Non-GAAP EPS of $0.71 beats by $0.01, revenue of $4.23B beats by $110M
by
Contributor since / Followers
Contributor since / Followers
1 month ago
- Teva Pharmaceutical press release (NYSE:TEVA): Q4 Non-GAAP EPS of $0.71 beats by $0.01.
- Revenue of $4.23B (-5.2% Y/Y) beats by $110M.
- FY25 revenue consensus of $17.09B, EPS consensus of $2.78
-
2025 Outlook
- Revenues of $16.8 – $17.4 billion
- Non-GAAP operating